Access to cancer treatment in India — everyone’s to blame

This piece on the Spicy IP blog is by a young patent law expert who now has family experience of the problems of cancer treatment in India. It is a thoughtful and well written piece which argues that innovative pharma companies, generics companies, state governments, Central government and insured individuals must all take some of the blame for India’s poor access to cancer care. The piece reflects the complexities and nuances of improving access.